Doxycycline (anhydrous) | 50805 | CAPSULE;ORAL | 40MG

Doxycycline anhydrous

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 11 USDMF, 8 CEP/COS, 5 KDMF, 7 NDC API, 12 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

FINISHED DOSAGE FORMULATIONS

202 FDF Dossiers, 78 FDA Orange Book, 36 Europe, 2 Canada, 38 Australia, 13 South Africa, 35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 150MG BASE, CAPSULE;ORAL - EQ 50MG BASE, CAPSULE;ORAL - EQ 75MG BASE, CAPSULE;ORAL - 40MG

RELATED EXCIPIENT COMPANIES

1 Evonik, 3 Rochem International Inc, 7 SPI Pharma, 2 Seqens, 9 DKSH, 2 Jai Radhe Sales, 5 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 34 BASF, 1 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 3 Finar, 13 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 38 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 32 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

89 Fillers, Diluents & Binders, 73 Coating Systems & Additives, 43 Controlled & Modified Release, 43 Disintegrants & Superdisintegrants, 43 Direct Compression, 39 Thickeners and Stabilizers, 34 Solubilizers, 31 Granulation, 28 Film Formers & Plasticizers, 22 Parenteral, 22 Taste Masking, 18 Topical, 18 Lubricants & Glidants, 18 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 9 Empty Capsules, 8 Emulsifying Agents, 8 Rheology Modifiers, 6 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

46 NEWS #PharmaBuzz

46 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 51 Finished Drug Prices

MARKET PLACE

36 APIs, 8 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

6 US Patents, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 50805 / DOSAGE - CAPSULE;ORAL - 40MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
DOXYCYCLINE(UNII: N12000U13O) (DOXYCYCLINE ANHYDROUS - UNII:334895S862)	DOXYCYCLINE ANHYDROUS	40mg

Inactive Ingredients

Ingredient Name	Owen Laboratories, Inc.
FERRIC OXIDE RED(1K09F3G675)
FERRIC OXIDE YELLOW(EX438O2MRT)
HYPROMELLOSES(3NXW29V3WO)
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A(NX76LV5T8J)
POLYETHYLENE GLYCOLS(3WJQ0SDW1A)
POLYSORBATE 80(6OZP39ZG8H)
SUCROSE(C151H8M554)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)
TRIETHYL CITRATE(8Z96QXD6UM)

Drug Product Composition: Doxycycline (anhydrous)